Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.3 USD | -0.76% | +2.36% | -66.49% |
May. 08 | UBS Adjusts Price Target on Stem to $2.50 From $5, Maintains Buy Rating | MT |
May. 02 | Transcript : Stem, Inc., Q1 2024 Earnings Call, May 02, 2024 |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
- According to Refinitiv, the company's ESG score for its industry is poor.
Strengths
- According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
- With regards to fundamentals, the enterprise value to sales ratio is at 1.06 for the current period. Therefore, the company is undervalued.
- The company appears to be poorly valued given its net asset value.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- Low profitability weakens the company.
- The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Renewable Energy Equipment & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-66.49% | 210M | D+ | ||
+15.50% | 20.51B | B | ||
-26.81% | 6.35B | B | ||
-16.91% | 3.1B | C+ | ||
-21.12% | 2.42B | B | ||
-19.11% | 2.06B | D+ | ||
+7.52% | 1.1B | C | ||
-29.24% | 1.1B | - | ||
-1.90% | 1.04B | - | - | |
+100.95% | 1.02B | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- STEM Stock
- Ratings Stem, Inc.